Literature DB >> 18628933

Gastrointestinal bleeding and cutaneous nodules.

Alka Mittal1, Daniel Felter, S Michelle Shiller, A David McCollum, Jeffrey P Lamont, Damien Mallat.   

Abstract

Entities:  

Year:  2008        PMID： 18628933      PMCID： PMC2446426          DOI： 10.1080/08998280.2008.11928420

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  19 in total

1.  Spontaneous rupture of recurrent gastrointestinal stromal tumor associated with neurofibromatosis type 1.

Authors:  Shin-Mae Wang; Ruey-An Chiang; Chin-Yuan Tzen; Shih-Ping Cheng; Tsang-Pai Liu
Journal:  J Chin Med Assoc       Date:  2005-11       Impact factor: 2.743

2.  Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1.

Authors:  Douglas R Stewart; Christopher L Corless; Brian P Rubin; Michael C Heinrich; Ludwine M Messiaen; Lisa J Kessler; Paul J Zhang; David G Brooks
Journal:  J Med Genet       Date:  2007-01       Impact factor: 6.318

3.  KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.

Authors:  B P Rubin; S Singer; C Tsao; A Duensing; M L Lux; R Ruiz; M K Hibbard; C J Chen; S Xiao; D A Tuveson; G D Demetri; C D Fletcher; J A Fletcher
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

Review 4.  From the archives of the AFIP: abdominal neoplasms in patients with neurofibromatosis type 1: radiologic-pathologic correlation.

Authors:  Angela D Levy; Nandini Patel; Nancy Dow; Robert M Abbott; Markku Miettinen; Leslie H Sobin
Journal:  Radiographics       Date:  2005 Mar-Apr       Impact factor: 5.333

5.  NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics.

Authors:  Johanna Andersson; Harri Sihto; Jeanne M Meis-Kindblom; Heikki Joensuu; Nina Nupponen; Lars-Gunnar Kindblom
Journal:  Am J Surg Pathol       Date:  2005-09       Impact factor: 6.394

6.  Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen's disease).

Authors:  Yutaka Takazawa; Shinji Sakurai; Yuji Sakuma; Tatsuru Ikeda; Jun Yamaguchi; Yoshio Hashizume; Shigeo Yokoyama; Atsushi Motegi; Masashi Fukayama
Journal:  Am J Surg Pathol       Date:  2005-06       Impact factor: 6.394

7.  Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.

Authors:  Charles D Blanke; Cathryn Rankin; George D Demetri; Christopher W Ryan; Margaret von Mehren; Robert S Benjamin; A Kevin Raymond; Vivien H C Bramwell; Laurence H Baker; Robert G Maki; Michael Tanaka; J Randolph Hecht; Michael C Heinrich; Christopher D M Fletcher; John J Crowley; Ernest C Borden
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

8.  Neurofibromatosis: MR imaging findings involving the head and spine.

Authors:  H H Shu; S A Mirowitz; F J Wippold
Journal:  AJR Am J Roentgenol       Date:  1993-01       Impact factor: 3.959

Review 9.  Multiple gastrointestinal stromal tumors and bilateral pheochromocytoma in neurofibromatosis.

Authors:  Klaus Kramer; Cornelia Hasel; Andrik J Aschoff; Doris Henne-Bruns; Peter Wuerl
Journal:  World J Gastroenterol       Date:  2007-06-28       Impact factor: 5.742

10.  Spine changes in neurofibromatosis.

Authors:  I Yaghmai
Journal:  Radiographics       Date:  1986-03       Impact factor: 5.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.